Trends Explored for Aesthetic Breast Augmentation From 2005 to 2021
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 26, 2023 -- For aesthetic breast augmentation, the most common technique remains smooth silicone prosthesis placed in the subpectoral plane through inframammary incision, according to a study published in the December issue of Plastic and Reconstructive Surgery.
Michael J. Stein, M.D., from Lenox Hill Hospital in New York City, and colleagues reviewed breast augmentation tracer data from 2005 to 2021 and compared trends for an early cohort (EC, 2005 through 2014) and a recent cohort (RC, 2015 through 2021).
The researchers found that compared with the EC, patients in the RC were older (35 versus 34 years), more likely to have ptosis >22 cm (23 versus 20 percent), less likely to smoke (8 versus 12 percent), and less likely to undergo preoperative mammogram (24 versus 29 percent). Inframammary incisions have become more common (80 versus 68 percent), while there has been a decline in use of periareolar incision (14 versus 24 percent). There was an increase observed in submuscular plane placement (56 versus 22 percent) and a decrease in subglandular placement (7 versus 19 percent). The most popular implants were silicone (82 versus 58 percent). From 2011 to 2016, there was an increase seen in textured implant use (2 to 16 percent), followed by a sharp decrease to 0 percent by 2021, in line with approvals and warnings from the U.S. Food and Drug Administration.
"Despite temporary adoption of textured implants in the RC, possibly related to enthusiasm for potential decreased capsular contracture risk in the subglandular plane, their use was overshadowed by a majority of smooth devices used by American Board of Plastic Surgery diplomates in primary breast augmentation," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-27 04:15
Read more
- U.K. Reports First Cluster Outside of Africa of New Mpox Variant
- Neurogene Reports Positive Interim Efficacy Data from First Four Low-Dose Pediatric Participants in NGN-401 Gene Therapy Clinical Trial for Rett Syndrome
- Weight-Loss Surgery for Teens Brings Lasting Benefit
- High Rates of Hep C Seen for Patients Presenting to ED With Opioid Overdose
- Darling Ingredients Announces Publication of Peer-Reviewed Collagen Peptides Study and its Impact on Post-Meal Blood Glucose Spikes
- Pandemic-Linked Worldwide Declines in Childhood Vaccination Not Yet Recovered
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions